ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Expensive Healthcare and Specialty Drugs Are Putting the Pressure On - New Study by Aimed Alliance and HR.com’s HR Research Institute

Jacksons Point, Ontario, Canada (Newsworthy.ai) Thursday May 16, 2024 @ 8:00 AM America/Toronto —

The rising cost of healthcare, particularly prescription drugs, continues to be a pressing concern for human resources (HR) professionals with each new plan year. A large majority (88%) express concerns about providing affordable health insurance to their employees. This increase in cost is largely driven by a select few high-cost products, notably specialty drugs. Projections for 2023 estimate the cost of specialty drugs to reach approximately about $311 billion, with three-quarters of medications in development belonging to this category.

In response to these concerns, Aimed Alliance, the Alliance for Patient Access, and HR.com's Research Institute conducted a study involving HR professionals to gather input from a cross-section of employers providing health insurance coverage to their employees. The 32-page research report, titled “Managing Prescription Drug Costs 2023-24,” along with an accompanying infographic, are now available for free download. These resources are designed to help HR professionals and employers better understand emerging trends in managing prescription costs and how these trends impact employees and their organizations.

While alternative funding programs (AFPs) are sometimes considered a solution for reducing drug costs, the study reveals that only 46 percent of respondents are familiar with AFPs. However, these programs raise significant concerns. Notably, there are concerns that in the U.S., specialty drugs obtained through AFPs may be sourced from international channels, raising legal implications not widely recognized by employers.

The report highlights that self-funded plans are especially likely to use AFPs, with over a quarter (28%) of self-insured employers currently employing them, compared to 16 percent overall.

“The impact of healthcare plans and these specialty drugs for employees that need them is forcing employers to think out of the box to reduce expenses,” stated Debbie McGrath, Chief Instigator and CEO of HR.com. “But they have to examine the risks and regulations of these alternatives.”

Download the full report and infographic to gain insights into the current trends shaping the attitudes, concerns, priorities, and skills of today’s HR professionals and how they will be transformed in the near future.

Download the Research Report: https://web.hr.com/82bna

About Aimed Alliance

Established in 2013 and based in Washington, D.C., Aimed Alliance is a non-profit health policy organization that works to protect and enhance the rights of healthcare consumers and providers. Aimed Alliance achieves this mission by conducting legal research and analysis; developing sound, patient-centered policy recommendations; and disseminating its findings to inform policymakers and increase public awareness. Learn more about Aimed Alliance at aimedalliance.org or on X (formerly Twitter) at @AimedAlliance.

About Alliance for Patient Access (AfPA)

Founded in 2006, the Alliance for Patient Access (AfPA) is a health policy organization that advocates for policies that support clinical decision-making, limit abusive utilization management techniques, and acknowledge each person’s individual healthcare needs deserve to be met. Learn more about AfPA at allianceforpatientaccess.org.

About HR.com and the HR Research Institute

The HR Research Institute (HRRI) helps you keep your finger on the pulse of HR! Powered by HR.com, the world’s largest HR community, the HRRI identifies key trends and best practices to help more than 2 million HR professionals and their organizations make strategic decisions with informed and insightful research findings.

Among the most productive and respected HR research institutes globally, the HRRI publishes dozens of high-quality reports every year across a wide array of HR topics. HR.com’s free membership offers many benefits, including access to over 250 exclusive primary research, state-of-the-industry reports, and infographics. These resources are published based on surveys developed with the assistance of a panel of thought leaders and industry experts on the advisory boards. Visit hr.com/hrresearchinstitute to maximize your HR potential. #hrresearchinstitute

Become a part of HR.com’s HR Research Influencer panel today. Participate in surveys, share your insights, and earn rewards.

Contact: info@hr.com
HR.com Newsroom

This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform.™

The reference URL for this press release is located here Expensive Healthcare and Specialty Drugs Are Putting the Pressure On - New Study by Aimed Alliance and HR.com’s HR Research Institute.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  248.40
+0.00 (0.00%)
AAPL  269.43
+0.00 (0.00%)
AMD  243.98
+0.00 (0.00%)
BAC  53.42
+0.00 (0.00%)
GOOG  290.59
+0.00 (0.00%)
META  631.76
+0.00 (0.00%)
MSFT  506.00
+0.00 (0.00%)
NVDA  199.05
+0.00 (0.00%)
ORCL  240.83
+0.00 (0.00%)
TSLA  445.23
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.